• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
CYHS1401980 达肝素钠注射液 dalteparin sodium Injection Chemical Drugs(6) Generic Drug 2016-07-05 辰欣药业股份有限公司 Cisen Pharmaceutical Co Ltd Certificate Issued 2017-06-28 view
CYHS1401979 达肝素钠注射液 dalteparin sodium Injection Chemical Drugs(6) Generic Drug 2016-07-05 辰欣药业股份有限公司 Cisen Pharmaceutical Co Ltd Certificate Issued 2017-06-28 view
CYHS1401978 达肝素钠注射液 dalteparin sodium Injection Chemical Drugs(6) Generic Drug 2016-07-05 辰欣药业股份有限公司 Cisen Pharmaceutical Co Ltd Certificate Issued 2017-06-28 view
JYHB2001704 达肝素钠注射液 dalteparin sodium Injection Chemical Drugs Supplementary Application 2020-09-07 辉瑞投资有限公司 Pfizer Investment Co Ltd Certificate Issued 2021-11-15 view
JYHB2001698 达肝素钠注射液 dalteparin sodium Injection Chemical Drugs Supplementary Application 2020-09-07 辉瑞投资有限公司 Pfizer Investment Co Ltd Certificate Issued 2021-11-15 view
JYHB1901077 达肝素钠注射液 dalteparin sodium Injection Chemical Drugs Supplementary Application 2019-08-31 辉瑞投资有限公司 Pfizer Investment Co Ltd Filed 2019-09-11 view
JYHB1901391 达肝素钠注射液 dalteparin sodium Injection Chemical Drugs Supplementary Application 2019-11-27 辉瑞投资有限公司 Pfizer Investment Co Ltd Certificate Issued 2020-03-03 view
JYHB2001700 达肝素钠注射液 dalteparin sodium Injection Chemical Drugs Supplementary Application 2020-09-07 辉瑞投资有限公司 Pfizer Investment Co Ltd Certificate Issued 2021-11-15 view
JYHB2001152 达肝素钠注射液 dalteparin sodium Injection Chemical Drugs Supplementary Application 2020-06-30 辉瑞投资有限公司 Pfizer Investment Co Ltd Filed 2020-07-01 view
JYHB1901073 达肝素钠注射液 dalteparin sodium Injection Chemical Drugs Supplementary Application 2019-08-31 辉瑞投资有限公司 Pfizer Investment Co Ltd Filed 2019-09-11 view
JYHB2001703 达肝素钠注射液 dalteparin sodium Injection Chemical Drugs Supplementary Application 2020-09-07 辉瑞投资有限公司 Pfizer Investment Co Ltd Certificate Issued 2021-11-15 view
JYHB1901076 达肝素钠注射液 dalteparin sodium Injection Chemical Drugs Supplementary Application 2019-08-31 辉瑞投资有限公司 Pfizer Investment Co Ltd Filed 2019-09-11 view
JYHB2001151 达肝素钠注射液 dalteparin sodium Injection Chemical Drugs Supplementary Application 2020-06-30 辉瑞投资有限公司 Pfizer Investment Co Ltd Filed 2020-07-01 view
JYHB1901072 达肝素钠注射液 dalteparin sodium Injection Chemical Drugs Supplementary Application 2019-08-31 辉瑞投资有限公司 Pfizer Investment Co Ltd Filed 2019-09-11 view
JYHB1901080 达肝素钠注射液 dalteparin sodium Injection Chemical Drugs Supplementary Application 2019-08-31 辉瑞投资有限公司 Pfizer Investment Co Ltd Filed 2019-09-11 view
JYHB2001702 达肝素钠注射液 dalteparin sodium Injection Chemical Drugs Supplementary Application 2020-09-07 辉瑞投资有限公司 Pfizer Investment Co Ltd Certificate Issued 2021-11-15 view
JYHB1901075 达肝素钠注射液 dalteparin sodium Injection Chemical Drugs Supplementary Application 2019-08-31 辉瑞投资有限公司 Pfizer Investment Co Ltd Filed 2019-09-11 view
JYHB2001150 达肝素钠注射液 dalteparin sodium Injection Chemical Drugs Supplementary Application 2020-06-30 辉瑞投资有限公司 Pfizer Investment Co Ltd Filed 2020-07-01 view
JYHB2001706 达肝素钠注射液 dalteparin sodium Injection Chemical Drugs Supplementary Application 2020-09-07 辉瑞投资有限公司 Pfizer Investment Co Ltd Certificate Issued 2021-11-15 view
JYHB1901079 达肝素钠注射液 dalteparin sodium Injection Chemical Drugs Supplementary Application 2019-08-31 辉瑞投资有限公司 Pfizer Investment Co Ltd Filed 2019-09-11 view